Recent Headlines
Within Biotechnology
Arthritis and Bacterial Infection Research Nabs Win for Stevens Student
Stevens undergrad demonstrates how bacteria infection plays a role in arthritis. - January 19, 2012 - Stevens Institute of Technology
Pratt & Miller Engineering Enters Sales Agent Agreement with Red Cedar Technology
Industry-leading engineering firm will resell HEEDS MDO software. - January 19, 2012 - Red Cedar Technology
AnaSpec Introduces Ultra-Sensitive SensoLyte® NADP/NADPH Assay Kit
AnaSpec, EGT Group, the provider of ultra-sensitive fluorimetric SensoLyte® line of assay kits is pleased to announce the release of the SensoLyte® Fluorimetric NADP/NADPH Assay Kit. This assay is a sensitive fluorimetric assay that detects NADP and NADPH without interfering with NAD/NADH. - January 19, 2012 - AnaSpec, EGT Group
AnaSpec Includes Ghrelin and Obestatin Peptides in GO® Collection
AnaSpec, EGT Group, a leading provider of integrated proteomic and genomic solutions, offers a wide range of ghrelin and obestatin GO® (catalog) peptides for research use. In 1999, Kojima and his group (1) reported the discovery of a growth hormone secretagogue that is involved in the release... - January 19, 2012 - AnaSpec, EGT Group
NovaTeinBio Advancing Research with New CD Antigen Solutions
Boston based biological reagents provider NovaTeinBio has recently announced to their client base that they will now be providing more CD (clusters of differentiation) antigen products than ever before. These new additions come as research companies across America look to specialists such as... - January 19, 2012 - Novatein Biosciences
AnaSpec Highlights Its Proprietary HiLyte Fluor™ Dye Collection
AnaSpec, EGT Group’s proprietary HiLyte Fluor™ dyes are a series of excellent fluorescent labeling dyes with fluorescence emissions that span the full visible and near infrared spectrum. The hydrophilic property of most of the HiLyte Fluor™ dyes makes conjugations to protein... - January 17, 2012 - AnaSpec, EGT Group
Nanion Celebrates Its 10th Anniversary - Still with a Strong Focus on New Innovations
Today, Nanion celebrates 10 years of innovation, scientific product development and successful roll-outs of several product families. Nanion is a success story of organic, revenue-based company growth and dedicated young professionals. - January 17, 2012 - Nanion Technologies GmbH
CrystalGenomics Scores KRW 3 Billion in Strategic Equity Investment from KSLSF, a Life Science Fund Backed by the City of Seoul and the Ministry of Knowledge Economy
CrystalGenomics, Inc. (KOSDAQ: CRYSTAL [083790]), a clinical stage biopharmaceutical company headquartered in Korea, has just announced that it has successfully raised KRW 3 Billion (USD 2.6 Million) in a private placement to the Korea Seoul Life Science Fund (KSLSF). This is the third time within... - January 16, 2012 - CrystalGenomics, Inc.
John Quackenbush to Speak at CHI’s Bioinformatics & Cancerinformatics Conference, February 21-23, San Francisco, CA
Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session. - January 12, 2012 - Cambridge Healthtech Institute
SignaBlok Awarded DARPA Contract to Support New Technology to Combat Sepsis
SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to introduce company’s new approach to the prevention and treatment of sepsis (blood poisoning). - January 12, 2012 - SignaBlok, Inc.
Aciont® To Present on VisulexTM Technologies at the 4th Ocular & Drug Discovery Conference
Aciont Inc. announced today that both Kongnara Papangkorn, Research Director and Sarah Abdulla Molokhia, Scientific Research Consultant, will present on Aciont’s Visulex technologies at the Global Technology Community’s 4th Ocular & Drug Discovery Conference, February 27-28, 2012,... - January 12, 2012 - Aciont Inc.
Autoscribe Launches US Operation
The formation of Autoscribe Informatics Inc., a wholly owned subsidiary of Autoscribe Ltd, has been announced. Based in Falmouth, MA, USA, it gives Autoscribe, the developers of Matrix software products, a much stronger presence in the US and Canadian markets. Zumatrix Inc. operated as... - January 12, 2012 - Autoscribe Informatics
CrystalGenomics to Present at J.P. Morgan Healthcare Conference on January 12
CrystalGenomics, Inc. (KOSDAQ: CRYSTAL (083790)), a clinical stage biopharmaceutical company headquartered in Korea, has just announced that Joong Myung Cho, Ph.D., President & CEO, will present an overview of CrystalGenomics’ business strategy and an update on its development pipeline on... - January 11, 2012 - CrystalGenomics, Inc.
NEXTflex™ Modules Lower the Cost of Next Generation Sequencing Sample Prep
Bioo Scientific recently launched the NEXTflex™ DNA, ChIP-Seq, and PCR-Free Modules, which were designed to lower the cost of library prep for high throughput users. Modules are available for each step in the library preparation protocol including end repair, adenylation, ligation and PCR. - January 06, 2012 - Bioo Scientific
Bioo Scientific Simplifies the Analysis of Apoptotic Bodies with the D-Pop™ Kit
Bioo Scientific launched the D-Pop™ Kit to capture apoptotic bodies from cell-free fluids and to extract DNA from them offering a non-invasive source of biomarkers for the diagnosis and prognosis of diseases. - January 05, 2012 - Bioo Scientific
BioPharm Systems to Host Webinar on Oracle Clinical and Remote Data Capture Implementation Standards and Best Practices
Leading provider of clinical trial, data, and drug safety solutions will examine various clinical data management and electronic data capture system implementation and usage best practices that all sponsors and clinical research organizations should consider to greatly increase the usability of the applications. - January 05, 2012 - BioPharm Systems
Kanguro Enters Finnish Biotech Sector with Its Magnetic Solution
Kanguro's magnetic solution helps attract more business opportunities for the biotech sector. - January 04, 2012 - Kanguro
Declan Doogan of Amarin to Keynote CHI’s Conference on Phase III Clinical Trials
Amarin’s CMO to lead line-up of thought leaders at Cambridge Healthtech Institute’s executive and scientific forum. - December 26, 2011 - Cambridge Healthtech Institute
BioPharm Systems and Valiance Partners to Host Webinar on How to Migrate Drug Safety and Pharmacovigilance Data Cost-Effectively and with Minimum Risk
Leading software implementation and migration experts will discuss how to successfully approach a drug safety and pharmacovigilance system migration project. - December 22, 2011 - BioPharm Systems
AnaSpec Highlights HiLyte Fluor™ Dyes Collection - for Labeling Amine and Thiol-Modified Oligos
AnaSpec is pleased to highlight their wide collection of amine and thiol reactive 6-isomeric dyes of fluoresceins and rhodamines, and AnaSpec’s own proprietary HiLyte Fluor™ dyes for labeling amine and thiol modified oligonucleotides. Fluorescent dye-labeled oligos are widely used as... - December 21, 2011 - AnaSpec, EGT Group
TransEnterix Closes $15M in Equity Financing
Second tranche of Series B to accelerate development and commercialization of new flexible surgical tools - December 18, 2011 - TransEnterix
New Lightning-Link® Rapid Antibody Labeling Kits Now for DyLight™ Dyes
The Lightning-Link® Rapid Antibody kits allow direct antibody labeling reactions to be set up in seconds and used within just 20 minutes. Novus has recently expanded their Lighting-Link® Rapid kits to include the following DyLight™ dyes. Lightning-Link® Rapid DyLight... - December 17, 2011 - Novus Biologicals
Novus New Lab Program - Receive 20% Off for New Labs
Novus Biologicals understands the funding constraints and logistical difficulties of starting a new lab. Therefore, Novus is proud to announce a New Lab Program, offering 20% off Novus purchases for your first 3 months. Additionally, Novus will provide a welcome kit full of useful tools for your... - December 16, 2011 - Novus Biologicals
Novus Products Now Available Through the UPENN Cell Center Stockroom
Novus is proud to announce that select products will now be available through the University of Pennsylvania’s Cell Center Stockroom. Researchers who order through the Cell Center Stockroom will receive a 20% discount off the regular list price and free shipping. The Cell Center Stockroom... - December 15, 2011 - Novus Biologicals
Red Cedar Technology Releases HEEDS MDO 6.0 and HEEDS POST 1.0
Newest versions of design optimization and post-processing software - December 14, 2011 - Red Cedar Technology
Fitzsimons Redevelopment Authority Announces Second Phase of Strategic Refocus with $8 Million Expansion to Bioscience Park Center with 37,000-Square-Foot Accelerator
The Fitzsimons Redevelopment Authority (FRA) is expanding its Bioscience Park Center (BPC) by roughly 50% with an $8 million, 37,000-square-foot accelerator structure. The new accelerator space will be leased to existing tenants graduating from the incubator and other companies in the modest growth stage. - December 12, 2011 - Fitzsimons Redevelopment Authority
SFL’s Public Affairs Now Covers Bioethics
SFL’s Public Affairs team, helping organizations shape EU rules, saw exciting expansion in 2011. - December 11, 2011 - SFL Regulatory Affairs & Scientific Communication Ltd
CoreTherm Medical, Inc. Expand Mobilizer Business by Signing Paul Almaguer in Dallas
CoreTherm Medical, Inc., today announced that they have signed a contract with Dallas/Ft Worth area-based Paul Almaguer to become a new mobilizer for their CoreTherm® system. - December 10, 2011 - CoreTherm Medical Inc.
Stevens Researcher Makes Inkjet-Printed Electronics Using Graphene
Dr. Woo Lee of Stevens and Partners in the US Army Win Academic R&D Award from Printed Electronics Conference and Tradeshow. - December 09, 2011 - Stevens Institute of Technology
Colorado BioScience Association Celebrates 2011 Industry Standouts
The Colorado BioScience Association (CBSA) honored the outstanding bioscience companies and individuals in the state during its 9th Annual Awards Dinner at the Downtown Denver Embassy Suites. The CBSA's Annual Awards program showcases the significant achievements in the state's bioscience industry throughout the year. - December 09, 2011 - Colorado BioScience Association
SFL Thanks Clients and Partners for Successful Collaborations
With the end of 2011 approaching, SFL can reflect on a very successful year of extension and expansion in all areas. The company’s client base has expanded internationally as demand has grown for its personalized and comprehensive services in the fields of Regulatory Affairs, Public Affairs, Legal Services and Medical Communication. - December 08, 2011 - SFL Regulatory Affairs & Scientific Communication Ltd
UNICEF and Stevens Professor Improve Drinking Water in Bangladesh
Dr. Xiaoguang Meng introduced pioneering technologies for effective, affordable, and easy to use water purification during a recent expedition to Bangladesh, where an environmental crisis affects the drinking water of tens of millions of people. - December 08, 2011 - Stevens Institute of Technology
DARPA Grant Streamlines Data for the Department of Defense
Researchers at Stevens Institute of Technology unify DoD data streams through competitive new DARPA grant. - December 07, 2011 - Stevens Institute of Technology
Pipette.com Now Has ISO 9001 and ANSI/NCSL Z540.3 Accreditation to Compliment the Existing ISO 17025 Accreditation for Pipette Calibration
Pipette.com is excited to announce the attainment of ISO 9001:2008 certification and ANSI/NCSL Z540-1-1994 accreditation on top of existing ISO 17025:2005 Accreditation. The ISO 17025 and ANSI/NCSL Z540.3-2006 accreditations were issued by A2LA. The ISO 9001 accreditation was issued by QAS... - December 04, 2011 - Accutek Laboratories
NovaTeinBio Introduce Hundreds of New ELISA Kit Products Through Their Company Catalogue
Biological reagents provider NovaTeinBio has recently announced that they have added several new products to their extraordinary catalogue of ELISA kit solutions. The company has made this move after a distinct increase in demand for ELISA kits, which provide researchers with increase accuracy from... - December 04, 2011 - Novatein Biosciences
Thermo Fisher Scientific Announces New Thermo Scientific Orion Meters
An entirely new expanded offering means no settling – get the right meter for the right application. - November 30, 2011 - Thermo Scientific
GenWay Biotech Launches Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011 First Multiple Biomarker Test to Predict Near Term MI
FirstMark, the diagnostic division of GenWay Biotech, Inc., today announced study results and the commercial launch of PREventTM. FirstMark PREvent is the first multiple biomarker test that accurately predicts near term (approximately 2-3 years) risk of myocardial infarction for suspected or confirmed coronary artery disease (CAD) patients. FirstMark PREvent is now available and will be targeted to primary care physicians and cardiologists. - November 24, 2011 - GenWay Biotech
Advanced Microplates Receives Funding Round
Biocroi, the Dublin-based biotech company has recently received €800k in funding to further its work on a unique range of multi-well microplates. These are for use in drug discovery research in the pharmaceutical and bio industries. - November 19, 2011 - Advanced Microplates by Biocroi
AVIPERO Announces JB1a Reverses Tissue Damage and Induces Tissue Repair in Emphysema
AVIPERO (Registered in Scotland SC353945) announced today the results of its first R&D therapeutic platform in non-stem cell tissue repair and regeneration. The principal candidate, JB1a, is an antibody targeting the cell surface adhesion receptor beta1 integrin. The preclinical study, funded... - November 18, 2011 - Avipero Ltd.
PharmaJet Receives Grand Challenges Explorations Funding
PharmaJet Inc. announced today that it will receive funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables researchers worldwide to pursue innovations that address persistent health and development challenges. Dr. Linda... - November 16, 2011 - PharmaJet, Inc.
Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus with Appointment of Four Key Leaders in the Bioscience Industry to Its Board of Directors
The Fitzsimons Redevelopment Authority (FRA) is adding four of the area's most well-known and successful leaders in the Bioscience Industry to its Board of Directors. Change in board composition is the result of a strategic refocus for the FRA, and those recently appointed to the board include: Donald M. Elliman, Jr.; William Freytag, PhD; James C. T. Linfield; and David Perez. - November 15, 2011 - Fitzsimons Redevelopment Authority
Photo Exhibit by Colorado BioScience Association Keynote Speaker Rick Guidotti Begins Friday, November 18, at VSA Colorado/Access Gallery, Santa Fe Arts District
Photos by Colorado BioScience Association (CBSA) Awards Dinner Keynote Presenter Rick Guidotti will be on display for a month, beginning November 18, at Denver's CSA Colorado/Access Gallery in the Santa Fe Arts District. Guidotti, award winning fashion photographer, is known worldwide for his dynamic images and important message about genetic difference. - November 14, 2011 - Colorado BioScience Association
Mitegen Announces Distribution Agreement with Helix Biotech in Malaysia
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed a distribution agreement with Helix Biotech (M) SDN BHD of... - November 12, 2011 - MiTeGen, LLC
Mitegen Announces Mutual Distribution Agreements with AJK Analytical Services
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed mutual distribution agreements with AJK Analytical Services. - November 12, 2011 - MiTeGen, LLC
Sleep and Consciousness Research Now Online
Lucid Scribe Database is an online sleep and consciousness research database that aims to document the effects of lucidity on dreams. The word lucid is defined as clarity, especially of thought. In regard to dreaming it refers to a state in which one is aware that one is dreaming, whilst one is... - November 11, 2011 - Lucid Scribe Database
Better Surfing Through Science at Stevens Institute of Technology
Stevens Institute of Technology doctoral candidate designs artificial reefs for coastal protection and teaches high school kids about engineering. - November 11, 2011 - Stevens Institute of Technology
Novus Biologicals Announces New ROBLD3 Antibody Made Using SDIX Genomic Antibody Technology™
Novus Biologicals announced today a new ROBLD3 antibody (catalog number NBP1-71687) for use in research on cell growth regulation. This ROBLD3 antibody was made using SDIX Genomic Antibody TechnologyTM. ROBLD3 is one of three individual proteins (ROBLD3, c11orf59 & MAPKSP1) that form the... - November 11, 2011 - Novus Biologicals
Announcing the Release of a Novel Tool for the Assessment of Porcine Islet Functionality: the Mercodia Porcine C-peptide ELISA
Mercodia announced the release of their new Porcine C-Peptide ELISA at the recent Cell Transplant Society (CTS) and International Xenotransplantation Association (IXA) meeting in Miami, Florida, October 23-26. This assay provides the type 1 diabetes, and more specifically the islet transplantation,... - November 10, 2011 - Mercodia Inc.
Dr. Alexander Sutin of Stevens Elected Acoustical Society of America Fellow
Dr. Sutin develops acoustical underwater monitoring for port and harbor security. - November 10, 2011 - Stevens Institute of Technology
NovaTeinBio Announce Introduction of Nearly 7000 Products to Their Antibody Collection
Biological reagents supplier NovaTeinBio has announced the addition of thousands of new products to their antibody product suite. Through these new product additions, which include nearly 7000 new primary antibodies for their clients’ high-priority research applications, the company is hoping... - November 10, 2011 - Novatein Biosciences